Table 1 Demographic and clinicopathologic information of the lung cases analyzed.
From: Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
Clinical Parameters | Cases n (%) | |
|---|---|---|
Age | ≥65 | 28 (51.9%) |
<65 | 26 (48.1%) | |
Gender | Male | 37 (68.5%) |
Female | 17 (31.5%) | |
Smoking history | Yes | 46 (85%) |
No | 6 (11%) | |
Unknown | 2 (3%) | |
Karnosfsky | ≥80 | 45 (83.3%) |
<80 | 9 (16.7%) | |
Histology | Squamous Cell Carcinoma | 21 (38.5%) |
Adenocarcinoma | 32 (59.6%) | |
Large Cell Carcinoma | 1 (1.9%) | |
Differentation grade | Good differentiated | 11 (20.4%) |
Moderate | 16 (29.6%) | |
Poor | 27 (50%) | |
Stage | I-II | 22 (40.7%) |
III | 18 (33.3%) | |
IV | 14 (26%) | |
Local/Advanced | Local (stage I II) | 22 (40.7%) |
Advanced (stage III-IV) | 32 (59.3%) | |
Progression | Yes | 26 (48.1%) |
No | 28 (51.9%) | |
Death | Yes | 25 (46.3%) |
No | 29 (53.7%) |